Using Machine Learning to Predict Soil Lead Relative Bioavailability

Shuang Zhang,Xiaoping Li,Tunyang Geng,Yu Zhang,Weixi Zhang,Xueming Zheng,He Sheng,Yueheng Jiang,Pengyuan Jin,Xuelian Kui,Huimin Liu,Ge Ma,Jiang Yun,Xiangyang Yan,Xu Zhang,Beatriz Galindo-Prieto,Frank J. Kelly,Ian Mudway
DOI: https://doi.org/10.1016/j.jhazmat.2024.136515
IF: 13.6
2024-01-01
Journal of Hazardous Materials
Abstract:Although the relative bioavailability (RBA) can be applied to assess the effects of Pb on human health, there is no definition and no specific data of Pb-RBA to different soil sources and endpoints in vivo. In this study, we estimated the Pb-RBA from different soil sources and endpoints based on machine learning. The Pb-BAc and Pb-RBA in soils were found to be mostly in the range of 20-80%, which is different from the USEPA Pb-RBA of 60% in soils. The mean Pb-RBA for different biological endpoints in vivo predicted using the RF model were 49.94 ± 18.65% for blood; 60.15 ± 26.62%, kidney; 60.90 ± 21.51%, liver; 50.70 ± 17.56%, femur; and 62.89 ± 16.64% as a combined measure. Pb-RBA of shooting range soils was 88.21 ± 16.92% (mean), spiked/aged soils 77.11 ± 14.05% and certified reference materials 73.70 ± 20.31%; agricultural soil 68.28 ± 18.93%, urban soil 64.36 ± 21.82%, mining/smelting soils 53.99 ± 17.66%, and industrial soils 47.71 ± 20.35%. This study is first to define the Pb-RBA according to various soil sources and endpoints in vivo with the objective of providing more accurate Pb-RBA data for soil lead risk assessment.
What problem does this paper attempt to address?